The Patent Finder

Shenzhen Chipscreen Biosciences Co., Ltd.

Also on record
Records under this name other than the patents Shenzhen Chipscreen Biosciences Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 16 patents it holds.

Showing 1 to 4 of 4 · Back to Shenzhen Chipscreen Biosciences Co., Ltd.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,244,751Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity
Term ended
Term ended Jun 20, 2025 · USPTO record
Term endedTerm ended Jun 20, 2025USPTO record
US 7,268,157Substituted arylalcanoic acid derivatives as PPAR pan agonists with potent antihyperglycemic and antihyperlipidemic activity
Term ended
Term ended Jul 8, 2024 · USPTO record
Term endedTerm ended Jul 8, 2024USPTO record
US 7,550,490Benzamide derivatives as histone deacetylase inhibitors with potent differentiation and anti-proliferation activity
Term ended
Term ended Feb 2, 2024 · USPTO record
Term endedTerm ended Feb 2, 2024USPTO record
US 7,192,970Noncyclic 1,3-dicarbonyl compounds as dual PPAR agonists with potent antihyperglycemic and antihyperlipidemic activity
Lapsed on the fee record
Ended Mar 20, 2011 · USPTO record
Lapsed on the fee recordEnded Mar 20, 2011USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited